Protection from COVID reinfections plummeted from 80% to 5% with omicron
With the rise of omicron came the fall of long-lasting protection from reinfection with the pandemic coronavirus SARS-CoV-2, ...
Smaller US winter COVID wave adds pressure to Pfizer turnaround
Health experts are seeing signs of a much smaller wave of U.S. COVID-19 cases this winter than in previous years, which could ...
The U.S. Is Having Its Mildest Covid Winter Yet
According to wastewater data aggregated by the Centers for Disease Control and Prevention, not only was there less Covid ...
CBS 58 News12h
A look back at the impact of COVID-19, 5 years later
It's been five years since COVID-19 officially became a global health emergency. A month later, the pandemic changed most aspects of everyday life. Years later, health experts ...
verywellhealth2d
Flu, COVID, and RSV: It's Peak Season
For the week ending Jan. 25, seasonal flu activity remains high and increasing. Clinical laboratories tested 129,378 ...
What is the difference between flu A and flu B? Experts on the symptoms
It's flu season right now, and the U.S. is in the midst of a wave that's straining hospitals. But not all influenza is the ...
The symptoms of influenza A and B can be identical, experts say. Here's what to know
It's flu season, but not all influenza is the same. If you're feeling sick, it helps to know the difference between flu A and ...
IFLScience on MSN3d
Nanoparticle Vaccine Could Protect Against Future COVID-19 Variants – Plus Other Coronaviruses
A newly developed vaccine against a group of viruses including SARS-CoV-2 is producing promising results in mice, part of the ...
School closures reduced Covid impact in most countries but not all: study
“We estimated that the intervention led to reductions in SARS-CoV-2 infections, peak hospital occupancy and deaths in most countries,” he said. “However, the study also found that, in a few cases, ...
HUB3d
Convalescent plasma offers a 'blueprint' for future pandemics
Hopkins researchers help secure full FDA approval to treat immunocompromised COVID-19 patients—paving the way to explore ...
Invivyd Announces Preliminary Fourth Quarter 2024 Financial Results, Strong Revenue Growth, and Reiterates Goal of Near-Term Profitability
PEMGARDA™ (pemivibart) net product revenue of $13.8 million, 48% growth over Q3 2024 net product revenue of $9.3 ...
Hindustan Times6d
Covid-19
So far there have been several variants of the virus -- B.1.1.7, B.1.351, P.1, Delta, B.1.617.2, BA.5. Omicron BF.7 strain is driving the current wave of Covid infections in China. As of now ...